Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein by Wu, J et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Site-specific inhibition of RNA polymerase II preinitiation
complex assembly by human cytomegalovirus IE86 protein
Citation for published version:
Wu, J, Jupp, R, Stenberg, RM, Nelson, JA & Ghazal, P 1993, 'Site-specific inhibition of RNA polymerase II
preinitiation complex assembly by human cytomegalovirus IE86 protein' Journal of Virology, vol. 67, no. 12,
pp. 7547-55.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of Virology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
JOURNAL OF VIROLOGY, Dec. 1993, p. 7547-7555
0022-538X/93/1 27547-09$02.00/0
Copyright ©) 1993, American Society for Microbiology
Site-Specific Inhibition of RNA Polymerase II Preinitiation
Complex Assembly by Human Cytomegalovirus IE86 Proteint
JUN WU,' RAY JUPP,2 RICHARD M. STENBERG,3 JAY A. NELSON,2 AND PETER GHAZAL' 4*
Department of Immunology, IMMI,' and Division of Virology, Department of Neuropharmacology,4 The Scripps
Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037; Department of Microbiology and
Immunology, Oregon Health Sciences University, Portland, Oregon 972012; and Department of Microbiology and
Immunology, Eastern Virginia Medical School, Norfolk, Virginia 235013
Received 22 July 1993/Accepted 7 September 1993
The human cytomegalovirus major immediate-early gene encodes several protein isoforms which autoregu-
late the major immediate-early promoter (MIEP). One of these isoforms, the IE86 protein (UL122, IE2), is a
DNA-binding protein that represses the MIEP through its cognate recognition sequence (designated the cis
repression signal [crs]) located between the TATA box and the initiation site of transcription. Purified
recombinant IE86 protein was shown to repress MIEP transcription in vitro, in a cis-acting mediated pathway,
with nuclear extracts from HeLa S3, U373-MG, and primary human foreskin fibroblast cells. Repression of the
MIEP by IE86 was shown by two criteria to be dependent on the direct interaction of IE86 with the crs element.
Core promoter constructs containing essentially the MIEP TATA box and crs element were also specifically
repressed by IE86 but not by a mutant IE86 protein, indicating the general transcription machinery as the
target for IE86 repression. Kinetic and template commitment experiments demonstrated that IE86 affects
preinitiation complex formation but not the rate of reinitiation. Sarkosyl inhibition experiments further
revealed that IE86 was unable to effect repression by either disassembling or preventing the elongation of a
preexisting transcription complex. Further, the ability of IE86 to interact with the DNA-binding subunit of
TFIID was shown not to be required for repression. These functional protein-DNA and protein-protein
interaction experiments demonstrate that IE86 specifically interferes with the assembly of RNA polymerase II
preinitiation complexes. The biological significance of these results and the precise mechanism by which IE86
represses transcription are discussed.
The immediate-early (IE) genes of human cytomegalovirus
(HCMV) encode transcriptional regulatory proteins which,
together with host-encoded transcription factors, temporally
regulate the developmental expression of the viral genome. We
are interested in understanding the role of viral and cellular
proteins in coordinating RNA polymerase II (RNAPII) activ-
ity associated with HCMV gene regulation.
The HCMV IE86 protein (also referred to as UL122 or IE-2
80- or 82-kDa protein) is translated from an mRNA derived
from region 1 and 2 genomic sequences of the major IE (MIE)
gene, which is transcriptionally regulated by the MIE promoter
(MIEP) (20, 37, 43, 44, 46). The IE86 protein is an activator of
a variety of promoters including those of the HCMV early
genes, as well as heterologous viral and cellular promoters (2,
3a, 5-8, 13, 17, 19, 24, 30, 35, 37-40, 42, 47-49). The precise
mechanism(s) by which this protein activates transcription is
not clearly understood. However, a recent study by Klucher et
al. (24) implicates antirepression of transcription by histone
HI as one possible mechanism underlying IE86 activation.
Another possibility for the promiscuous action of IE86 might
involve the direct interaction of IE86 with general transcrip-
tion factors required for establishing RNAPII initiation com-
plexes. In support of this suggestion, IE86 has been shown to
directly interact with the TATA box-binding protein (TBP) in
the absence of DNA (14) and with promoter-bound TBP (22).
Transcription initiation from eukaryotic protein-encoding
genes is a multistep process that requires RNAPII and as many
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as seven general transcription factors (reviewed in reference
50). The TBP subunit of the general transcription factor TFIID
mediates the recognition of the TATA sequence element and
represents the first step in the formation of a preinitiation
complex (50). Significantly, IE86 has been shown to stimulate
the binding of TBP to promoter DNA, thus affecting a critical
rate-limiting step in the assembly of an initiation complex (22).
Furthermore, the TBP-contacting domain of IE86 responsible
for mediating the interaction of IE86 with promoter-bound
TBP partially overlaps with the N-terminal activation region of
the protein (22).
In addition to the ability of this protein to stimulate tran-
scription, IE86 has been shown to negatively autoregulate the
MIEP (1, 4, 16, 28, 36, 38, 42). Negative regulation of the
MIEP by IE86 is dependent on a sequence element termed the
cis repression signal (crs) located between the TATA box and
the cap site (4, 28, 36). IE86 can bind directly to the crs element
(25) via a DNA binding domain located in the C terminus of
the protein (21, 29). Evidence that the binding of IE86 to the
crs element is responsible for repression has recently been
provided by the ability of an IE86 maltose-binding fusion
protein to repress transcription in vitro (29). Since the crs
element is positioned immediately proximal to the TATA box,
it is possible that IE86 might affect TBP binding to the
promoter site. Recently, we have shown that TBP and IE86 can
simultaneously bind to their cognate recognition sites on the
MIEP (21), suggesting that IE86 might influence subsequent
assembly steps in the preinitiation process. These steps involve
TBP's association via protein-protein interactions with the
general transcription factors TFIIA (DA complex) and TFIIB
(DB complex) or with both TFIIA and TFIIB (DAB complex).
The DAB or DB complex acts as the preinitiation complex for
7547
Vol. 67, No. 12
7548 WU ET AL.
the entry of RNAPII, mediated by TFIIF, into the transcrip-
tion cycle (reviewed in reference 50). Recently, a number of
factors that interact with TBP have been shown to functionally
repress basal transcription (18, 31, 32). Therefore, the interac-
tion of IE86 with TBP may also be essential for the negative
regulation of the MIEP by IE86. Alternatively, repression of
MIEP activity by IE86 may proceed by a mechanism indepen-
dent of this interaction. For instance, IE86 may effect inhibi-
tion of transcription post-preinitiation complex formation by
either directly disassembling a preexisting complex or hinder-
ing the processivity of an elongating RNAPII complex.
Autorepression of the MIEP by IE86 is critical for MIEP
activity which may ultimately affect the permissiveness of the
virus within the cell. Therefore, knowledge of the step(s) in the
assembly of transcription complexes at which IE86 effects
inhibition will be fundamental to the understanding of this
process. In this study, we have attempted to address these
issues by defining the molecular requirements by which IE86
autorepresses the MIEP in an in vitro transcription system.
Evidence is presented to indicate at which step in the tran-
scription process IE86 exerts its negative effects.
MATERIALS AND METHODS
Recombinant plasmids. The DNA templates pMIEP
(- 1145/+1 12)CAT, pMIEP( - 65/+7)CAT, and pMIEP(mcrs)
CAT used in the in vitro transcription assays have been de-
scribed previously (1, 12). The DNA template pRR56/5 was a
kind gift from B. Fleckenstein. The construction of the His-6-
tagged IE86 expression clone (p86-6His) and the generation of
IE86 mutant expression clones for IE86mZn, IE86AN6,
IE86AMS, IE86AC2, IE86AN1AC2, and IE86AN6AC2 are de-
scribed elsewhere (21, 22).
Purification of recombinant proteins. Escherichia coli har-
boring each of the expression plasmids was grown to an optical
density at 550 nm of 0.7 to 0.8 prior to induction with 200 pLg
of isopropyl-3-D-thiogalactopyranoside (IPTG) per ml. Cells
were harvested after 90 to 120 min of induction and stored at
- 70°C. Cells were thawed and then lysed in buffer containing
50 mM sodium phosphate (pH 7.8), 1 mM phenylmethylsulfo-
nyl fluoride, 1% Tween 20, 1 M NaCl, and 1 mg of lysozyme
per ml for 20 min prior to sonication. Following centrifugation
at 16,000 rpm in a Sorvall SS34 rotor, the cleared lysate was
subjected to Ni2+ chelate chromatography (Qiagen, Chat-
sworth, Calif.) (26) over a column equilibrated in buffer
containing 50 mM sodium phosphate (pH 7.8), 500 mM NaCl,
and 10% glycerol. After being washed with this buffer, the
column was washed in a similar buffer at pH 6.0. A final wash
was performed with the latter buffer containing 75 mM imida-
zole prior to elution in the same buffer containing 500 mM
imidazole. Fractions containing each of the proteins were
pooled and dialyzed against 50 mM sodium phosphate (pH
7.8)-250 mM NaCl-1 mM 3-mercaptoethanol-30% glycerol.
Analysis of the protein fractions by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis indicated that the IE86 and
IE86 mutant proteins were approximately 90% pure.
Nuclear extract preparation and in vitro transcription
assays. The nuclear extracts derived from HeLa S3, U373-MG,
and primary human foreskin fibroblast (HFF) cells were
prepared from exponentially growing cells as described previ-
ously (9), with the exception that all buffers contained 10 mM
(each) leupeptin, pepstatin, and aprotinin as well as 0.5 mM
phenylmethylsulfonyl fluoride. Protein concentration was de-
termined by the Bradford method (3).
The transcription reaction conditions (in 25 RI) were as
described previously (11). Routinely, poly(U) polymerase ac-
tivity present in the extracts was used as an internal control to
account for variability during the workup of the RNA samples.
Optimal DNA concentrations were determined for the con-
structs pMIEP(- 1145/+112)CAT and pMIEP(mcrs)CAT in
the different cell types. These corresponded to 10 and 20 p.g/ml
for pMIEP(- 1145/+112)CAT and pMIEP(mcrs)CAT in the
HeLa nuclear cell extract, respectively. For U373-MG tran-
scription reactions, 15 [Lg of the wild-type and mutant tem-
plates per ml was used. The pMIEP(- 1145/+112)CAT and
pMIEP(mcrs)CAT templates were linearized with EcoRl-
HindIII and PvuII, respectively, prior to use. The templates
pMIEP( - 65/+7)CAT and pRR56/5 were each linearized with
EcoRI and HinidIII and used in the transcription reactions at a
concentration of 25 pLg/ml. In the template commitment ex-
periments, pMIEP(- 1145/+112)CAT was resected with
EcoRI and HindIll for template 1 and PvuII for template 2,
respectively. The final concentration of these templates used in
the template commitment assays was 3 pLg/ml. The Sarkosyl
addition experiments designed to dissociate the initiation and
elongation steps of transcription were based on the studies of
Hawley and Roeder (15).
RESULTS
In vitro repression of transcription by IE86. To examine
whether the ability of IE86 to bind the crs element is a
prerequisite to the mechanism by which IE86 mediates repres-
sion of MIEP transcription, in vitro transcription from the
MIEP with nuclear extracts prepared from both nonpermissive
and permissive cells was analyzed in the absence or presence of
increasing amounts of purified recombinant IE86 protein. In
nonpermissive HeLa cell nuclear extract, 75 nM IE86 was
observed to abolish transcription from a template containing
the complete MIEP control sequence, pMIEP(- 1145/
+112)CAT (Fig. IA, lane 3). More importantly, repression of
this construct was also observed in the presence of IE86 in an
in vitro transcription assay using extracts prepared from a
permissive cell line (U373-MG cells) and permissive primary
HFF cells (Fig. lB and C, lanes 2 to 5). A concentration of
IE86 similar (corresponding to an equivalent number of mol-
ecules of IE86 per DNA template) to that observed for the
HeLa transcription was also required in reaction mixtures from
the permissive cells to shut off transcription. By contrast, no
significant repression of transcription from an MIEP template
[pMIEP(mcrs)CAT], in which clustered point mutations were
present in the crs element, was observed with either the HeLa,
U373-MG, or HFF nuclear extracts (Fig. IA to C, lanes 7 to 10
compared with lane 6). The pMIEP(mcrs)CAT construct has
been previously shown to be nonresponsive to IE86 repression
in vivo (1). Although marginal repression by IE86 at high
concentrations (> 150 nM) was observed with the pMIEP
(mcrs)CAT template in HFF nuclear extracts (Fig. IC, lanes 9
and 10), lower concentrations of IE86 (75 nM), which abol-
ished transcription with the wild-type template, were unable to
effect inhibition with pMIEP(mcrs)CAT (Fig. 1C, compare
lane 3 with lane 8). These results also indicate that the
inhibition by recombinant IE86 is not due to a trivial reason,
such as the presence of a contaminating RNase activity.
To test directly whether the binding of IE86 to the crs
element is required to repress transcription from the MIEP,
the effect of a mutant form of IE86 that is incapable of binding
the crs element was investigated. The mutant of IE86
(IE86mZn) used in these experiments contains a 2-amino-acid
(aa) substitution mutation of the two cysteine residues (C-428
and C-434 converted to serine residues) located within the
putative zinc finger domain and has been previously shown to
J . VlIROL.
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FIG. 1. In vitro repression of MIEP transcription by IE86 with
HeLa (A), U373-MG (B), and HFF (C) nuclear extracts. Each of the
nuclear extracts was tested, with pMIEP(- 1145/+112)CAT (lanes I
to 5 and 11 to 14) and pMIEP(mcrs)CAT (lanes 6 to 10), in the
absence (lanes 1 and 6) or presence of increasing amounts of IE86
wild-type protein (86) (lanes 2 and 7, 38 nM; lanes 3 and 8, 75 nM;
lanes 4 and 9, 150 nM; and lanes 5 and 10, 190 nM) or IE86 zinc finger
mutant protein (86mZn) (lanes 11, 80 nM; lanes 12, 150 nM; lanes 13,
320 nM; and lanes 14, 400 nM). Nuclear extracts, templates, and IE86
proteins as indicated were preincubated for 30 min prior to the
addition of NTPs and the initiation of transcription. Reactions were
stopped 45 min after addition of NTPs. Arrows indicate specific
transcript. Note that in U373-MG transcription reactions a prema-
turely terminated transcript [most notable for the pMIEP(mcrs)CAT
template] is also observed.
be phenotypically defective in binding the crs element (21, 29).
In both the permissive (U373-MG and HFF) and the nonper-
missive (HeLa) cell extracts, no significant repression of tran-
scription was observed even in the presence of 320 nM
IE86mZn (Fig. 1A to C, lanes 13). However, a marginal
decrease was observed with 400 nM IE86mZn (Fig. 1A to C,
lanes 14), but this most likely reflects a nonspecific effect at this
extremely high protein concentration. These experiments in
combination with previous data (21, 25, 29) demonstrate that
the direct binding of IE86 to the crs element is a requirement
for mediation of transcriptional repression. The observation
that IE86 is capable of repressing transcription in a variety of
different cell extracts indicates that its effects are not cell type
dependent, thus implicating the general transcription machin-
ery as the target for IE86 action.
IE86 repression is independent of the upstream enhancer
and downstream transcriptional control domains of the
MIEP. To examine directly whether IE86 repression of the
MIEP involves stimulatory sequences from the enhancer do-
main, a DNA template (pRR56/5) in which sequences up-
stream of nucleotide position -65 have been deleted but
which contains downstream (to nucleotide position +54) con-
trol elements was assayed for in vitro repression by IE86. Note
that the ability of the upstream enhancer elements and the
downstream control elements to stimulate in vitro transcrip-
FIG. 2. IE86 repression of the MIEP core promoter. (A) In vitro
transcription (HeLa nuclear extract) from pRR56/5 template in the
absence of added IE86 protein (lanes 1 and 6) and with increasing
concentrations of either wild-type IE86 (lanes 2 to 5) or mutant
IE86mZn (lanes 7 to 10) corresponding to 38 nM (lanes 2 and 7), 75
nM (lanes 3 and 8), 150 nM (lanes 4 and 9), and 190 nM (lanes 5 and
10) of recombinant protein. (B) In vitro repression of core-promoter
template pMIEP(-65/+7)CAT. Lanes are as described for panel A.
Arrows, specific transcript.
tion from the MIEP has been previously shown (11, 12). In the
presence of increasing concentrations of IE86, transcription
from the pRR56/5 template was shown to be repressed by IE86
in a dose-dependent manner (Fig. 2A, lanes 2 to 5). A
complete inhibition of transcription was observed with a
concentration of IE86 between 75 and 150 nM. To show that
the repressive effect was specific, a similar titration experiment
was performed with increasing concentrations of an IE86
mutant protein (IE86mZn). In this experiment (Fig. 2A, lanes
6 to 10), repression of transcription was not observed in the
presence of 190 nM IE86mZn protein. These experiments
indicate that the upstream enhancer domain is not required for
repression by IE86.
To examine further whether the downstream activation
domain, in the absence of the enhancer domain, could be a
requirement for IE86 repression, the DNA template
pMIEP(-65/+7)CAT, which encompasses MIEP sequences
between nucleotide positions -65 and +7, was tested in the in
vitro repression assay. This construct essentially contains the
TATA and crs element but lacks the upstream enhancer and
downstream transcriptional control domains. Similar to the
pRR56/5 template, pMIEP(-65/+7)CAT was found to be
repressed by IE86 in a dose-dependent manner (Fig. 2B, lanes
2 to 5), in which complete inhibition of transcription was
observed with a 75 nM concentration of IE86 (Fig. 2B, lane 3).
Furthermore, repression was not observed with this template
in the presence of increasing concentrations of the IE86mZn
protein, indicating the specificity of the repression observed
with the IE86 protein (Fig. 2B, lanes 6 to 10). These experi-
ments indicate that IE86 can repress the core promoter of the
MIEP which is dependent on the assembly of the general
transcription factors and RNAPII.
IE86 acts on RNAPII preinitiation complex formation but
not on reinitiation or elongation steps. To elucidate the
possible mechanism by which IE86 interacts with the general
transcription machinery, a series of kinetic and Sarkosyl inhi-
bition experiments were designed. In the first experiment (Fig.
3A), we examined whether IE86 could interfere with the
elongation step of a committed complex. Elongation of com-
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FIG. 3. IE86 protein acts on RNAPII preinitiation complex forma-
tion but not on reinitiation or elongation steps. (A) pMIEP( -1145/
+ 11 2)CAT resected at the EcoRI site (generating runoff transcripts of
365 nucleotides) was preincubated with HeLa cell nuclear extract for
30 min. Transcriptions were started by adding NTPs and Sarkosyl at a
final concentration of 0.025% (wt/vol) (lanes 2 to 8). IE86 protein (190
nM final concentration) was added at the times indicated (lanes 3 to 8).
Reactions were stopped 45 min after addition of NTPs. Transcription
without Sarkosyl and IE86 protein (lane 1) was taken as the control for
multiple rounds of transcription. (B) Preincubation was the same as
described above. IE86 protein was added at 30 min (lanes 1 to 4).
Transcriptions were started by adding NTPs and Sarkosyl at the times
indicated. For the control (lane 5) without IE86, transcription was
started by adding NTPs and Sarkosyl at 30 min. Each reaction was
stopped after 30 min of elongation time. (C) pMIEP(- 1145/
+112)CAT and HeLa nuclear extracts were preincubated for 30 min,
and then transcription was started by adding NTPs. IE86 protein (190
nM final concentration) was added as indicated (lanes 1 to 9). The
reaction was stopped 45 min after the addition of NTPs. Transcription
repressed by IE86 protein was compared with transcription without
IE86 protein (lane 10). NE, nuclear extract.
mitted preinitiation transcription complexes is insensitive to
the presence of Sarkosyl (0.025%), whereas the initial assem-
bly of the transcription complex is disrupted. Thus, preinitia-
tion complexes allowed to assemble prior to the addition of
Sarkosyl and nucleoside triphosphates (NTPs) will be limited
to a single round of transcription (15). In the presence of
Sarkosyl, the effect of IE86 on the elongation step was
analyzed by adding IE86 at different times during the elonga-
tion process. A summary of the protocol is shown schematically
below Fig. 3A. Briefly, template and nuclear extract were
preincubated to permit the formation of committed preinitia-
tion complexes. NTPs and Sarkosyl were added to each
reaction after 30 min to initiate and prevent further rounds of
transcription, respectively. Subsequently, IE86 was added at
various times after the addition of NTPs and Sarkosyl and
reactions were terminated after 45 min. Figure 3A, lane 1,
represents a control experiment which shows the level of
transcription in the absence of both Sarkosyl and IE86. The
higher intensity of this transcript (compare with lane 2)
indicates that multiple rounds of transcription have occurred.
For the MIEP construct, the calculated rate of polymerization
of the transcript was from 0.2 to 0.6 nucleotides per s (49a).
Repression was not observed when IE86 was added during the
elongation process (Fig. 3A, lanes 3 to 6 compared with control
lane 2), suggesting that IE86 was incapable of inhibiting the
elongation of RNAPII complexes.
Competent preinitiation complexes (formed in the absence
of NTPs) are only those complexes which are capable of
rapidly initiating transcription upon addition of NTPs to the
reaction. Therefore, in the second experiment (Fig. 3B), the
ability of IE86 to disassemble preformed preinitiation com-
plexes was addressed. Template DNA was preincubated with
nuclear extract for 30 min to permit assembly of the preinitia-
tion complexes. IE86 was then added, to allow for the inter-
action of IE86 with committed preinitiation complexes at
designated times prior to the initiation of a single round of
transcription (Fig. 3B). The elongation time after the addition
of NTPs and Sarkosyl was 30 min for each reaction. The
amount of competent preinitiation complexes was assessed by
the quantity of transcripts on the gel. The protocol followed is
shown schematically below Fig. 3B. A decrease in the quantity
of runoff transcripts with increasing exposure to IE86 would be
observed if IE86 disassembled competent preinitiation com-
plexes. However, IE86 was not capable of repressing transcrip-
tion from the preformed preinitiation complexes (Fig. 3B,
lanes 1 to 4 compared with control lane 5), suggesting that this
step in the transcription process is not the critical step for
IE86-mediated repression.
In the third experiment, we investigated whether IE86 can
inhibit the formation of preinitiation complexes. As shown in
the protocol summary (Fig. 3C), IE86 was added to the
transcription reaction at different times during formation of an
RNAPII preinitiation complex as well as during the initiation/
reinitiation stages (post-addition of NTPs). The preincubation
and the initiation/reinitiation times indicated in Fig. 3C refer
to time allowed for preinitiation complex assembly and pro-
ductive transcription from committed complexes, respectively.
The template pMIEP(-1145/+112)CAT DNA was incubated
with the nuclear extract for 30 min at 25°C, during which IE86
was added at 0, 10, 20, and 30 min. At 30 min, NTPs were
added, and subsequently, IE86 was included in the reactions at
40, 50, 60, 70, and 75 min. Each reaction was stopped 45 min
after NTP addition, and the amount of transcript produced in
each reaction was monitored by gel electrophoresis.
IE86 disruption of preinitiation complex formation would be
indicated by a decrease in transcription during the preincuba-
J. VIROL.
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tion period only. However, if IE86 repressed transcription
subsequent to preinitiation complex formation, its effect on
transcription would be predicted to occur both before and after
addition of NTPs. Repression of transcription by IE86 was
effective within the first 10 min during the formation of the
preinitiation transcription complex (Fig. 3C, lanes 1 and 2
compared with lane 10). Inhibition of transcription by IE86
gradually decreased between 10 and 30 min (Fig. 3C, lanes 3
and 4). Upon initiation of a committed preinitiation complex,
the amount of transcript produced remained constant with no
observed repression (Fig. 3C, lanes 5 to 9). This experiment
demonstrated that IE86 affected a relatively early step in the
formation of an RNAPII preinitiation complex (Fig. 3C). Since
the conditions of this experiment (Fig. 3C) were not restricted
to a single round of transcription, components of the preini-
tiation complex still present at the promoter site would enable
reinitiation of transcription after engagement of RNAPII in
the first round. If IE86 were able to repress transcription at this
step, an inhibitory effect of IE86 after addition of NTPs would
have been observed. However, IE86 failed to repress transcrip-
tion under these conditions, in which initiation and reinitiation
complexes were allowed to form (that is, post-NTP addition)
(Fig. 3C, lanes 5 to 9), suggesting that IE86 cannot affect the
reinitiation step in transcription. In summary, these three
experiments (Fig. 3A to C) are consistent with the conclusion
that IE86 targets specifically the formation of a preinitiation
complex.
Committed preinitiation complexes are refractory to repres-
sion by IE86. In order to independently confirm the role of
IE86 in the inhibition of preinitiation complex assembly, we
performed template commitment experiments in which initia-
tion complexes were preformed on one experimental template
and then challenged with a second virgin template while
concomitantly initiating transcription by the addition of NTPs.
Subsequently, IE86 was added to the reaction at various times
after initiation, and the relative level of transcription was
measured from both templates. The pMIEP(- 1145/+1 12)CAT
construct was used to generate both template I and template 2
by truncating the DNA at different sites downstream of the cap
site so that the respective runoff transcripts could be readily
distinguished by gel electrophoresis and consequently moni-
tored simultaneously in a single transcription reaction.
First, we established conditions that permitted approxi-
mately equivalent levels of transcription from simultaneously
added template 1 and 2 DNAs in the absence of IE86 (Fig. 4,
lane 1). The results of this experiment demonstrate that there
are sufficient levels of transcription factors in the reaction for
assembly and elongation of transcription complexes on both
templates I and 2. With these conditions, the ability ofIE86 to
simultaneously inhibit initiation complexes on both templates
and 2 was examined. In a manner parallel to that of the
previous kinetic experiments (Fig. 3C, lanes I to 4), IE86 was
incubated with the templates (1 and 2) and nuclear extract at
0, 5, 10, 20, and 30 min prior to the addition of NTPs. The
reaction was stopped 30 min after NTP addition, and the
amount of transcript produced in each reaction was monitored
by gel electrophoresis. A schematic summary of this protocol is
shown in Fig. 4, part I. The results of this experiment (Fig. 4,
lanes 2 to 6 compared with control lane 1) demonstrate the
ability of IE86 to inhibit initiation complexes on both tem-
plates 1 and 2 with maximal inhibition occurring within the first
10 min of the formation of the preinitiation complexes (lanes
2 to 4). Those reactions in which IE86 was added within 10 to
30 min of preinitiation complex formation (Fig. 4, lanes 4 to 6)
varied slightly in the extent of repression observed for template
I relative to template 2. The reason for this observation is
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FIG. 4. Template commitment assays. pMIEP( - 1145/+1 15)CAT
was resected by EcoRI and HindIII (template 1) and PvuII (template
2), respectively. Templates 1 and 2 generated predicted transcripts of
365 and 265 nucleotides (indicated by arrows), respectively (lane 1). (I)
Both templates (each at a final concentration of 3 pg/ml) and HeLa
nuclear extract (NE) were preincubated for 30 min. IE86 protein was
added (190 nM final concentration) at the times indicated (lanes 2 to
6). (II) Template 1 was first preincubated with nuclear cxtract for 30
min, and then template 2 and NTPs were added to start transcription.
IE86 protein was added as indicated (lanes 7 to 11). (III) The
experimental procedure is exactly the same as for part II except that
template 2 was first preincubated with nuclear extract (lanes 12 to 16).
All reactions were stopped after 30 min of elongation time (after IE86
addition).
unclear but might indicate different rates of assembly of
initiation complexes on the templates, different rates of pro-
cessivity of RNAPII complexes, or different rates of sequestra-
tion of IE86. Nevertheless, these experiments show that there
are sufficient amounts of IE86 present in the reaction to inhibit
transcription complex formation on both templates.
To test the template commitment and repression of the
initiation complexes by IE86, the operations outlined schemat-
ically in Fig. 4, parts II and III, were performed. If a competent
preformed complex survived interference by IE86 on templatc
1 and IE86 inhibited the preinitiation complex assembly on
template 2, there would be preferential transcription from
template 1 relative to template 2. In the experiment whose
results are shown in Fig. 4, part II, transcription complexes
were allowed to assemble on template 1 in the absence ofIE86.
After 30 min, template 2 and NTPs were added and were
followed by the addition of IE86 to the reaction at 30, 35, 40,
50, and 60 min. The reaction was stopped 30 min after IE86
addition, and the amount of transcript produced in each
reaction was monitored by gel electrophoresis. Similar levels of
transcription from templates 1 and 2 were observed in reac-
tions which did not include IE86, indicating that transcription
factors were not limiting (data not shown). As predicted, the
preformed preinitiation complexes on template 1 were resis-
tant to inhibition by IE86 while preinitiation complex forma-
tion on template 2 was sensitive to repression by IE86 (Fig. 4,
lanes 7 to 11).
In the reciprocal template commitment experiment (Fig. 4,
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part III), initiation complexes were committed to template 2 in
the absence of IE86 and the assembly of preinitiation com-
plexes in the presence of IE86 was kinetically monitored with
template 1. Comparison of the relative levels of transcription
from templates 1 and 2 revealed a preferential transcription of
template 2 over that of template 1 (Fig. 4, lanes 12 to 16).
These results further demonstrate that IE86 represses tran-
scription by disrupting the assembly but not disassembly of
RNAPII preinitiation transcription complexes.
IE86 repression is independent from its ability to associate
with promoter-bound TBP. A number of nuclear factors which
repress preinitiation transcription complex formation have
been described elsewhere (10, 18, 23, 31, 32, 34). These factors
either prevent TBP from binding to the TATA box (10, 23, 34)
or directly interact with promoter-bound TBP to inhibit re-
cruitment of TFIIB (18, 31, 32). We have previously shown that
the binding of IE86 to the crs element does not preclude TBP
from interacting with the MIEP TATA box (21). However,
IE86 has been shown to bind TBP directly (14, 22). Therefore,
one mechanism by which IE86 might inhibit preinitiation
complex formation is via a direct association with TBP in the
context of the crs element. To examine this hypothesis directly,
mutant forms of IE86 compromised in their ability to bind
either promoter-bound TBP or the crs element or both were
assayed for their ability to repress transcription in vitro. The
IE86 mutants used in these experiments are represented
schematically in Fig. SB. Briefly, IE86AN6 encodes an N-
terminal deletion of the first 153 aa residues of IE86 while
IE86AMS encodes an internal deletion of 13 aa residues
(positions 141 to 153 of IE86); both of these mutants retain the
ability to interact with the crs element but are incapable of
binding promoter-bound TBP (21, 22). In contrast, IE86z\C2,
IE86AN1AC2, and IE86AN6AC2 are truncated at aa position
541 of IE86 and have lost their ability to bind the crs element
(21). In addition, IE86AN1zAC2 and IE86AN6AC2 have N-
terminal truncations at aa positions 48 and 154, respectively.
While IE86AN1AC2 retains the ability to interact with promot-
er-bound TBP, IE86AN6AC2 is defective for this TBP inter-
action (22). The template pMIEP(-1145/+112)CAT was pre-
incubated for 10 min with increasing concentrations of the
purified IE86 mutant proteins; preincubation was followed by
the addition of nuclear extract and NTPs. The reaction was
stopped 45 min after NTP addition, and the amount of
transcript produced in each reaction was monitored by gel
electrophoresis.
The results of the experiment shown in Fig.SA demonstrate
that IE86AN6 (lanes 5 to 7) and IE86AMS (lanes 8 to 10), but
not IE86AC2 (lanes 11 to 13), IE86AN1AC2 (lanes 14 to 16),
and IE86AN6AC2 (lanes 17 to 19), were capable of repressing
the MIEP in a dose-dependent manner. However, the extent to
which IE86AN6 and IE86AMS repress transcription is slightly
less than that of the wild-type protein. Since IE86AN6 and
IE86/MS can bind the crs element but are incapable of
interacting with promoter-bound TBP, we suggest that the
mechanism by which IE86 represses preinitiation complex
formation is not entirely dependent on its ability to interact
with promoter-bound TBP, in the context of the crs element.
By contrast, those mutants that lack the ability to bind the crs
element (IE86/C2, IE86AN1AC2, and IE86AN6AC2, includ-
ing IE86mZn [Fig. 1, lanes 11 to 14] and IE55 [an isoform
variant ofIE86] [data not shown]) were ineffectual in repress-
ing transcription from the MIEP, further emphasizing that the
site-specific interaction ofIE86 with the crs element is critical
for the mechanism underlying IE86 repression.
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FIG. 5. IE86 repression is independent from its ability to contact
promoter-bound TBP. (A) Transcription assays were performed as
described in the legend to Fig. 2 with IE86 wild type (lanes 2 to 4),
IE86AN6 (lanes 5 to 7), IE86AvMS (lanes 8 to 10), IE86AC2 (lanes 11
to 13), IE86AN1AC2 (lanes 14 to 16), and IE86AN6AC2 (lanes 17 to
19). Concentrations of IE86 and mutant forms used in the reactions
were 38 nM for lanes 2, 5, 8, 11, 14, and 17; 75 nM for lanes 3, 6, 9, 12,
15, and 18; and 190 nM for lanes 4, 7, 10, 13, 16, and 19. The effects of
different IE86 proteins on transcription were compared with the
control (lane 1). Note that these mutant proteins bound either DNA or
TBP with efficiencies comparable to that of the wild-type IE86 protein.
(B) Diagram of IE86 wild-type protein and different mutated IE86
proteins used in the transcription assays. Numbers refer to amino acid
positions, except for the numbers shown in the rod, which designate
amino acids encoded by exons 2, 3, and 5 of the MIE gene. Abbrevi-
ations: NLS, nuclear localization sequence; ZnF, putative zinc finger
domain; TCD, TBP-contacting domain; D, DNA binding domain; A,
activation domain; R, autorepression domain.
DISCUSSION
As part of our efforts to understand and elucidate the role of
cellular and viral transcription factors in coordinating RNAPII
activity associated with HCMV promoters, we have under-
taken an in vitro analysis of repression by the IE86 protein, one
of the predominant products expressed from the MIE gene
during HCMV infection.
IE86 acts at an early stage of initiation complex assembly.
Consistent with previous studies (1, 4, 16, 21, 25, 28, 29, 36, 38,
42), we find that autorepression by IE86 is dependent on the
crs element in which direct binding ofIE86 to this element (21,
25, 29) is a prerequisite for repression of transcription (refer-
ence 29 and Fig. 1). Transcription from eukaryotic protein-
encoding genes is a sequential process involving preinitiation
complex formation, initiation, elongation, and reinitiation
steps which requires the orderly assembly and disassembly of
transcriptional factors on the core promoter (50). In principle,
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any one of these steps could be a point of control by promoter-
selective factors such as IE86. Previous studies have suggested,
but not proven, that the transcriptional repression mediated by
IE86 probably involves a blockage of, or interaction with, the
RNAPII transcription complex (21, 25, 29). In this report, we
have demonstrated that IE86 directly inhibits the formation of
transcription initiation complexes on the MIEP by specifically
occluding the assembly of an RNAPII preinitiation complex.
Evidence is also presented which indicates that IE86 is unable
to block either reinitiation or elongation steps in the transcrip-
tion process. Further, our experiments demonstrate that once
a preinitiation complex is formed, IE86 is unable to effect
inhibition.
The mode of IE86 repression revealed by this study is likely
to have biological implications for understanding HCMV
MIEP autoregulation during a permissive infection. First,
these results indicate that, during an infection, the ability of
IE86 to autorepress the MIEP will be dependent on the
physical occupation of the promoter by transcription com-
plexes. Thus, during the initial stages of an acute infection or
during activation from a quiescent state upon cellular differ-
entiation, the MIEP will be occupied by cellular transcription
factors prior to the accumulation of IE86. At these stages of
infection, IE86 would be predicted to be restricted in its ability
to repress transcription from the MIEP. However, following
DNA replication of the HCMV genome, the MIEP is likely to
be stripped of transcription complexes, providing an ideal
opportunity for IE86-mediated repression of the MIEP
present in the newly replicated viral genomes. In this regard, it
is important to note that during a permissive infection IE86
persists throughout the HCMV replication cycle (37, 41).
The second implication relates to the innate potency mani-
fested by the enhancer domain of the HCMV MIEP. Strate-
gically, if a strong promoter was required to be tightly auto-
regulated, a repressor would ideally be deployed to block an
early step in the transcription process. The location of the IE86
binding site (crs element) in the vicinity of initiating complexes
and the demonstrated ability of IE86 to inhibit preinitiation
complex formation, one of the earliest steps in the transcrip-
tion process, most likely reflect strong evolutionary pressure to
regulate such a potent promoter. In addition to these possible
implications, several important conclusions about the mecha-
nism by which IE86 regulates transcription complex assembly
follow from our results and are discussed below.
Possible mechanism by which IE86 protein negatively auto-
regulates transcription. While significant advances have been
made in understanding the role of sequence-specific DNA-
binding proteins in the selective activation of eukaryotic pro-
moters, considerably less is known about the mechanism(s) by
which regulatory proteins repress transcription. Several pro-
posed models (which are not mutually exclusive) for transcrip-
tional repression have been recently suggested (reviewed in
reference 27). These include competition for an activator
protein's DNA binding site, which is the simplest and probably
the most common form of repression; quenching, in which the
repressor interferes with the activation potential but not the
binding of an activator protein; and direct repression, when the
negative control factor directly blocks the activity of the basal
transcription complex.
Our experiments support the notion that IE86 can function
as a direct repressor, by interfering with the assembly of the
basal transcription complex. Recently, a number of inhibitors
of transcription complex assembly have been described (18, 31,
32). These inhibitory factors function by directly associating
with TBP to block recruitment of preinitiation factors to
promoter sites. Like these proteins, IE86 can interact with
TBP, but our finding that IE86 derivatives that are unable to
bind promoter-bound TBP can function as repressors indicates
that IE86 inhibits basal transcription via a distinct mechanism.
These findings are in agreement with a recent study by Macias
and Stinski (29) in which a chimeric form of IE86 truncated at
aa position 290 was also observed to repress MIEP transcrip-
tion in vitro.
An alternative mechanism for direct repression of preinitia-
tion complex assembly involves simply blocking the binding of
general factors to the core promoter. Examples of this type of
repression have been documented for both cellular and viral
DNA-binding proteins (10, 23, 34). Similar to IE86, all of these
proteins not only function as activator proteins but can also
repress transcription from selective promoters (in a DNA-
binding-dependent manner) by competing with the interaction
of recombinant TBP (or native TFIID) with the TATA box
(10, 23, 34). Previously, we have shown that the binding of IE86
to its cognate sequence element (crs) does not preclude
recombinant TBP interactions with the TATA box (21), sug-
gesting that the function of IE86 repression is different from
these examples. However, it is plausible that IE86 will block
the binding of the multisubunit native TFIID isolated from
nuclei rather than that of the recombinant TBP subunit.
Alternatively, repression mediated by IE86 binding to the crs
element could involve the induction of a conformational
change in the DNA that prevents the assembly of the preini-
tiation complex.
The results of this study, together with experimental evi-
dence from other studies (21, 22, 25, 29), have eliminated a
number of potential mechanisms and suggest that the IE86
protein can sterically interfere with the proper assembly of the
preinitiation transcription complex. Since IE86 has been
shown to bind to its DNA target (crs) prior to, or simulta-
neously with, TBP binding the TATA box, the binding of
TFIIB (the next factor recruited to the preinitiation complex)
is arguably the target of IE86-mediated repression. Moreover,
TFIIB has previously been shown to interact in the DB
complex distal to the TATA box in a position likely to be
occupied by promoter-bound IE86 (50). Although this model is
speculative, it offers an explanation for all the available data, as
well as providing predictive value for future experiments.
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